We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Generics Makers to Help Fill Gaps in BE Testing Guidance
FDA Asks Generics Makers to Help Fill Gaps in BE Testing Guidance
To make it easier for generics firms to create versions of complex drugs, the FDA is asking industry to identify drug products it would like to see bioequivalence testing guidances written for.